Global Circulating Tumor Cell (CTC) Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 01-Oct-2018
No. of pages: 136

Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.

Scope of the Report:

This report focuses on the Circulating Tumor Cell (CTC) Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Circulating Tumor Cell (CTC) Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- ApoCell, Inc. (US)

- Biocep Ltd. (Israel)

- Biocept, Inc. (US)

- Biofluidica Microtechnologies LLC (US)

- Celltraffix Inc. (US)

- Clearbridge Biomedics (Singapore)

- Creatv Microtech, Inc. (US)

- Cynvenio Biosystems, Inc. (US)

- Epic Biosciences Inc. (US)

- Fluxion Biosciences, Inc. (US)

- Ikonisys, Inc. (US)

- IVDiagnostics, Inc. (US)

- Janssen Diagnostics LLC (US)

- QIAGEN Hannover GmbH (Germany)

- RARECELLS SAS (Italy)

- ScreenCell (France)

- STEMCELL Technologies, Inc. (Canada)

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- CTC Enrichment

- CTC Detection

Market Segment by Applications, can be divided into

- Hospitals and clinics

- Pharmaceuticals and biotechnology companies

- Academic research institutes

- CROs

There are 15 Chapters to deeply display the global Circulating Tumor Cell (CTC) Diagnostics market.

Chapter 1, to describe Circulating Tumor Cell (CTC) Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Circulating Tumor Cell (CTC) Diagnostics, with sales, revenue, and price of Circulating Tumor Cell (CTC) Diagnostics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Circulating Tumor Cell (CTC) Diagnostics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Circulating Tumor Cell (CTC) Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Circulating Tumor Cell (CTC) Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Circulating Tumor Cell (CTC) Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Circulating Tumor Cell (CTC) Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 CTC Enrichment
1.2.2 CTC Detection
1.3 Market Analysis by Applications
1.3.1 Hospitals and clinics
1.3.2 Pharmaceuticals and biotechnology companies
1.3.3 Academic research institutes
1.3.4 CROs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ApoCell, Inc. (US)
2.1.1 Business Overview
2.1.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ApoCell, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Biocep Ltd. (Israel)
2.2.1 Business Overview
2.2.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocept, Inc. (US)
2.3.1 Business Overview
2.3.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocept, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biofluidica Microtechnologies LLC (US)
2.4.1 Business Overview
2.4.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celltraffix Inc. (US)
2.5.1 Business Overview
2.5.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celltraffix Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Clearbridge Biomedics (Singapore)
2.6.1 Business Overview
2.6.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Creatv Microtech, Inc. (US)
2.7.1 Business Overview
2.7.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Creatv Microtech, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cynvenio Biosystems, Inc. (US)
2.8.1 Business Overview
2.8.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cynvenio Biosystems, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Epic Biosciences Inc. (US)
2.9.1 Business Overview
2.9.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Epic Biosciences Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Fluxion Biosciences, Inc. (US)
2.10.1 Business Overview
2.10.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fluxion Biosciences, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ikonisys, Inc. (US)
2.11.1 Business Overview
2.11.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ikonisys, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 IVDiagnostics, Inc. (US)
2.12.1 Business Overview
2.12.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 IVDiagnostics, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Janssen Diagnostics LLC (US)
2.13.1 Business Overview
2.13.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 QIAGEN Hannover GmbH (Germany)
2.14.1 Business Overview
2.14.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 RARECELLS SAS (Italy)
2.15.1 Business Overview
2.15.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 ScreenCell (France)
2.16.1 Business Overview
2.16.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 STEMCELL Technologies, Inc. (Canada)
2.17.1 Business Overview
2.17.2 Circulating Tumor Cell (CTC) Diagnostics Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 STEMCELL Technologies, Inc. (Canada) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Circulating Tumor Cell (CTC) Diagnostics Manufacturer Market Share in 2017
3.3.2 Top 6 Circulating Tumor Cell (CTC) Diagnostics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Circulating Tumor Cell (CTC) Diagnostics Market Analysis by Regions
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Regions (2013-2018)
4.2 North America Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
4.3 Europe Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
4.5 South America Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
5 North America Circulating Tumor Cell (CTC) Diagnostics by Countries
5.1 North America Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Countries
5.1.1 North America Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Countries (2013-2018)
5.2 United States Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
5.3 Canada Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
5.4 Mexico Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
6 Europe Circulating Tumor Cell (CTC) Diagnostics by Countries
6.1 Europe Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Countries
6.1.1 Europe Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
6.3 UK Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
6.4 France Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
6.5 Russia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
6.6 Italy Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics by Countries
7.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Countries (2013-2018)
7.2 China Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
7.3 Japan Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
7.4 Korea Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
7.5 India Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
8 South America Circulating Tumor Cell (CTC) Diagnostics by Countries
8.1 South America Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Countries
8.1.1 South America Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
8.3 Argentina Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
8.4 Colombia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics by Countries
9.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
9.3 UAE Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
9.4 Egypt Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
9.5 Nigeria Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
9.6 South Africa Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
10 Global Circulating Tumor Cell (CTC) Diagnostics Market Segment by Type
10.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales and Market Share by Type (2013-2018)
10.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 CTC Enrichment Sales Growth and Price
10.2.1 Global CTC Enrichment Sales Growth (2013-2018)
10.2.2 Global CTC Enrichment Price (2013-2018)
10.3 CTC Detection Sales Growth and Price
10.3.1 Global CTC Detection Sales Growth (2013-2018)
10.3.2 Global CTC Detection Price (2013-2018)
11 Global Circulating Tumor Cell (CTC) Diagnostics Market Segment by Application
11.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Application (2013-2018)
11.2 Hospitals and clinics Sales Growth (2013-2018)
11.3 Pharmaceuticals and biotechnology companies Sales Growth (2013-2018)
11.4 Academic research institutes Sales Growth (2013-2018)
11.5 CROs Sales Growth (2013-2018)
12 Circulating Tumor Cell (CTC) Diagnostics Market Forecast (2018-2023)
12.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales, Revenue and Growth Rate (2018-2023)
12.2 Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Regions (2018-2023)
12.2.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Forecast (2018-2023)
12.2.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Forecast (2018-2023)
12.2.4 South America Circulating Tumor Cell (CTC) Diagnostics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Market Forecast (2018-2023)
12.3 Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Type (2018-2023)
12.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Forecast by Type (2018-2023)
12.3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share Forecast by Type (2018-2023)
12.4 Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Application (2018-2023)
12.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Forecast by Application (2018-2023)
12.4.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Circulating Tumor Cell (CTC) Diagnostics Picture
Table Product Specifications of Circulating Tumor Cell (CTC) Diagnostics
Figure Global Sales Market Share of Circulating Tumor Cell (CTC) Diagnostics by Types in 2017
Table Circulating Tumor Cell (CTC) Diagnostics Types for Major Manufacturers
Figure CTC Enrichment Picture
Figure CTC Detection Picture
Figure Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Applications in 2017
Figure Hospitals and clinics Picture
Figure Pharmaceuticals and biotechnology companies Picture
Figure Academic research institutes Picture
Figure CROs Picture
Figure United States Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure France Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure China Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure India Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Circulating Tumor Cell (CTC) Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Table ApoCell, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table ApoCell, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table ApoCell, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocep Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocept, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Biocept, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Biocept, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biofluidica Microtechnologies LLC (US) Basic Information, Manufacturing Base and Competitors
Table Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Biofluidica Microtechnologies LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celltraffix Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Celltraffix Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Celltraffix Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Clearbridge Biomedics (Singapore) Basic Information, Manufacturing Base and Competitors
Table Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Clearbridge Biomedics (Singapore) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Creatv Microtech, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Creatv Microtech, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Creatv Microtech, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cynvenio Biosystems, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Cynvenio Biosystems, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Cynvenio Biosystems, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Epic Biosciences Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Epic Biosciences Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Epic Biosciences Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Fluxion Biosciences, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Fluxion Biosciences, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Fluxion Biosciences, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ikonisys, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table Ikonisys, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Ikonisys, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IVDiagnostics, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table IVDiagnostics, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table IVDiagnostics, Inc. (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Diagnostics LLC (US) Basic Information, Manufacturing Base and Competitors
Table Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table Janssen Diagnostics LLC (US) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Hannover GmbH (Germany) Basic Information, Manufacturing Base and Competitors
Table QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table QIAGEN Hannover GmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RARECELLS SAS (Italy) Basic Information, Manufacturing Base and Competitors
Table RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table RARECELLS SAS (Italy) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ScreenCell (France) Basic Information, Manufacturing Base and Competitors
Table ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table ScreenCell (France) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table STEMCELL Technologies, Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table STEMCELL Technologies, Inc. (Canada) Circulating Tumor Cell (CTC) Diagnostics Type and Applications
Table STEMCELL Technologies, Inc. (Canada) Circulating Tumor Cell (CTC) Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales by Manufacturer (2016-2017)
Figure Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Manufacturer in 2016
Figure Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Manufacturer in 2017
Table Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Manufacturer (2016-2017)
Figure Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Circulating Tumor Cell (CTC) Diagnostics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Circulating Tumor Cell (CTC) Diagnostics Manufacturer (Revenue) Market Share in 2017
Figure Global Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Global Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales by Regions (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Regions (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Regions (2013-2018)
Figure Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions in 2013
Figure Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Regions in 2017
Figure North America Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Europe Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure South America Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure North America Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2013-2018)
Table North America Circulating Tumor Cell (CTC) Diagnostics Sales by Countries (2013-2018)
Table North America Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries (2013-2018)
Figure North America Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries in 2013
Figure North America Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries in 2017
Table North America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2013-2018)
Table North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2013
Figure North America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2017
Figure United States Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Canada Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Mexico Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Europe Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2013-2018)
Table Europe Circulating Tumor Cell (CTC) Diagnostics Sales by Countries (2013-2018)
Table Europe Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries (2013-2018)
Table Europe Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2013-2018)
Figure Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2016
Figure Europe Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2017
Figure Germany Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure UK Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure France Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Russia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Italy Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales by Countries (2013-2018)
Table Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries 2017
Table Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2013-2018)
Figure Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries 2017
Figure China Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Japan Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Korea Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure India Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure South America Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2013-2018)
Table South America Circulating Tumor Cell (CTC) Diagnostics Sales by Countries (2013-2018)
Table South America Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries (2013-2018)
Figure South America Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries in 2017
Table South America Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2013-2018)
Table South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2017
Figure Brazil Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Argentina Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Colombia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales by Countries (2013-2018)
Table Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Countries in 2017
Table Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue by Countries (2013-2018)
Table Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure UAE Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Egypt Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure Nigeria Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Figure South Africa Circulating Tumor Cell (CTC) Diagnostics Sales and Growth Rate (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales by Type (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales Share by Type (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Type (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Revenue Share by Type (2013-2018)
Figure Global CTC Enrichment Sales Growth (2013-2018)
Figure Global CTC Enrichment Price (2013-2018)
Figure Global CTC Detection Sales Growth (2013-2018)
Figure Global CTC Detection Price (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales by Application (2013-2018)
Table Global Circulating Tumor Cell (CTC) Diagnostics Sales
  • 2018 Cancer Diagnostics Market: US, Europe, Japan--Supplier Country Shares, Segment Volume and Sales Forecasts, Laboratory Universe
    Published: 09-Nov-2018        Price: US 2850 Onwards        Pages: 11
    This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.Contains 11 pages and 3 tables......
  • 2018 Tumor Marker Testing Market: US, Europe, Japan--Supplier Country Shares, Strategic Profiles of Leading Cancer Diagnostic Reagent and Instrument Manufacturers, Country Volume and Sales Forecasts
    Published: 09-Nov-2018        Price: US 3850 Onwards        Pages: 104
    This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 104 pages an......
  • Global Prostate Cancer Diagnostics Market Research Report 2018
    Published: 02-Nov-2018        Price: US 2900 Onwards        Pages: 112
    This report studies the global Prostate Cancer Diagnostics market status and forecast, categorizes the global Prostate Cancer Diagnostics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Genomic Health - Abbott - OPKO - Siemens Healthcare - Dia......
  • Global PSA Test Market Research Report 2018
    Published: 02-Nov-2018        Price: US 2900 Onwards        Pages: 119
    This report studies the global PSA Test market status and forecast, categorizes the global PSA Test market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Abbott - Siemens Healthcare - DiaSorin - Roche - Beckman Coulter - PerkinElmer - ......
  • 2018 Cancer Diagnostics Market Shares, Test Volume and Sales Forecasts by Country
    Published: 29-Oct-2018        Price: US 2450 Onwards        Pages: 11
    This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.Contains 11 pages and 3 tables......
  • Global Pap Tests and HPV Tests Market Research Report 2018
    Published: 26-Oct-2018        Price: US 2900 Onwards        Pages: 116
    This report studies the global Pap Tests and HPV Tests market status and forecast, categorizes the global Pap Tests and HPV Tests market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Abbott Laboratories - Arbor Vita Corporation - Becton, Dickinson and Company......
  • Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018
    Published: 24-Oct-2018        Price: US 2900 Onwards        Pages: 118
    This report studies the global Checkpoint Inhibitors for Treating Cancer market status and forecast, categorizes the global Checkpoint Inhibitors for Treating Cancer market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Bristol-Myers Squibb(BMS) - Merck - Roche......
  • Global Cancer Diagnostics Market Growth 2018-2023
    Published: 19-Oct-2018        Price: US 3660 Onwards        Pages: 134
    This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market. Ove......
  • Global Pap Tests and HPV Tests Market Insights, Forecast to 2025
    Published: 09-Oct-2018        Price: US 3900 Onwards        Pages: 118
    Global Pap Tests and HPV Tests market size will increase to Million US$ by 2025, from Million US$ in 2017, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Pap Tests and HPV Tests. This report researches the worldwide Pap Tests and HPV Tests market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs